Eylea

Money

FDA To Review Teva and Alvotech Drug That Could Compete With Regeneron’s Eylea

Key Takeaways Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug Administration agreed to review their AVTO6 treatment…

Read More »
Back to top button